IGF-1 impacts neocortical interneuron connectivity in epileptic spasm generation and resolution

Area of Science:

• Neuroscience
• Developmental Biology
• Epilepsy Research

Background:

• Epileptic spasms following perinatal brain injury lack understood mechanisms.
• Reduced Insulin-like Growth Factor 1 (IGF-1) and GABAergic deficits are observed in affected patients.
• Interneurons play a crucial role in regulating neuronal excitability.

Purpose of the Study:

• To investigate the role of IGF-1 deficiencies in neocortical interneurons in the generation of epileptic spasms.
• To explore the potential of IGF-1 and its analogues as therapeutic agents for infantile epileptic spasms syndrome (IESS).

Main Methods:

• Quantitative immunohistochemistry to analyze interneuron markers and IGF-1 expression in epileptic rat models and IESS patient samples.
• Viral vector-mediated reduction of IGF-1 receptor (IGF-1R) in neonatal mice to study interneuron development.
• Treatment of epileptic rats with the IGF-1 derived tripeptide (1-3)IGF-1.

Main Results:

• Neocortical interneurons expressing GAD, parvalbumin, or synaptotagmin 2 co-express IGF-1.
• Epileptic conditions showed reduced expression of these interneuron markers and IGF-1, specifically within interneurons.
• Interneuron connectivity was diminished in tandem with IGF-1 deficiencies in both animal models and human samples.
• Neonatal reduction of IGF-1R led to decreased interneuron connectivity.
• (1-3)IGF-1 treatment abolished spasms, restored interneuron connectivity, and normalized neocortical IGF-1 levels.

Conclusions:

• Interneuron-specific IGF-1 deficiencies, potentially due to impaired autocrine signaling, contribute to epileptic spasm generation.
• Dysmaturation of interneurons resulting from IGF-1 deficits is implicated in this neurodevelopmental disorder.
• (1-3)IGF-1 shows promise as a disease-modifying therapy by rescuing interneuron connectivity and suppressing spasms.